(SBRA) Sabra Healthcare REIT - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US78573L1061

SBRA: Real Estate Properties, Loans, Preferred Equity, Joint Ventures

As of September 30, 2024, Sabra Healthcare REIT Inc. (NASDAQ: SBRA) maintained a diversified portfolio of 373 real estate properties, strategically focused on healthcare-related assets. The portfolio comprised 233 skilled nursing and transitional care facilities, 39 senior housing communities under lease agreements, 68 senior housing communities managed by third-party operators, 18 behavioral health facilities, and 15 specialty hospitals and other healthcare facilities. Additionally, Sabra held 14 investments in loans receivable, including three mortgage loans and 11 other loans, along with five preferred equity investments and two stakes in unconsolidated joint ventures. The properties spanned the United States and Canada, providing 37,793 beds and units, emphasizing Sabras role as a significant player in healthcare real estate.

The companys diversified approach reduces dependency on any single healthcare sector, mitigating risks associated with market fluctuations. Sabras investments in loans receivable and preferred equity further enhance its revenue streams, while joint ventures provide exposure to growth opportunities without full capital commitment. This balanced strategy aligns with Sabras objective of generating stable cash flows and long-term value for shareholders.

Ticker Symbol: SBRA Exchange: NASDAQ Type: common stock Country Origin: United States GICS Sub Industry: Health Care REITs Average Volume 20d: 2213385 Last Price: 17.42 SMA 20: 17.47 SMA 50: 17.10 SMA 200: 17.00 ATR: 0.48 Market Cap: 4127.76M USD P/E: 32.13 P/E Forward: 8.71 P/B: 1.51 P/S: 5.87 RoE: 4.62 3-Month Forecast: - Technical Outlook: SBRA is trading near its SMA 20 and SMA 50, indicating potential sideways movement. The SMA 200 suggests support at $17.00. Low ATR of 0.48 signals reduced volatility, with price fluctuations expected within a narrow range. - Fundamental Outlook: The forward P/E of 8.71 reflects market expectations of improved earnings. Sabras diversified portfolio and exposure to healthcare real estate position it favorably amid rising demand for senior housing and healthcare services. However, the current P/E of 32.13 may indicate elevated valuations, potentially limiting near-term upside.

Additional Sources for SBRA Stock

SBRA Stock Overview

Market Cap in USD 4,163m
Sector Real Estate
Industry REIT - Healthcare Facilities
GiC Sub-Industry Health Care REITs
IPO / Inception 2002-04-02

SBRA Stock Ratings

Growth Rating 62.3
Fundamental 47.8
Dividend Rating 60.7
Rel. Strength 15.1
Analysts 4.07/5
Fair Price Momentum 19.40 USD
Fair Price DCF 28.00 USD

SBRA Dividends

Dividend Yield 12m 7.00%
Yield on Cost 5y 14.85%
Annual Growth 5y -2.33%
Payout Consistency 89.7%

SBRA Growth Ratios

Growth Correlation 3m 80.3%
Growth Correlation 12m 59.5%
Growth Correlation 5y 59.1%
CAGR 5y 16.87%
CAGR/Max DD 5y 0.46
Sharpe Ratio 12m 2.50
Alpha 29.40
Beta 0.301
Volatility 24.43%
Current Volume 1878.5k
Average Volume 20d 2255k
What is the price of SBRA stocks?
As of May 02, 2025, the stock is trading at USD 17.62 with a total of 1,878,544 shares traded.
Over the past week, the price has changed by +0.69%, over one month by +0.69%, over three months by +6.11% and over the past year by +36.26%.
Is Sabra Healthcare REIT a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Sabra Healthcare REIT (NASDAQ:SBRA) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.81 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SBRA as of May 2025 is 19.40. This means that SBRA is currently undervalued and has a potential upside of +10.1% (Margin of Safety).
Is SBRA a buy, sell or hold?
Sabra Healthcare REIT has received a consensus analysts rating of 4.07. Therefor, it is recommend to buy SBRA.
  • Strong Buy: 7
  • Buy: 1
  • Hold: 6
  • Sell: 0
  • Strong Sell: 0
What are the forecast for SBRA stock price target?
According to ValueRays Forecast Model, SBRA Sabra Healthcare REIT will be worth about 21 in May 2026. The stock is currently trading at 17.62. This means that the stock has a potential upside of +18.9%.
Issuer Forecast Upside
Wallstreet Target Price 19.5 10.7%
Analysts Target Price 19.8 12.5%
ValueRay Target Price 21 18.9%